LENZ Therapeutics, Inc. short interest in 2021
In 2021, LENZ Therapeutics, Inc.'s disclosed short interest ran from 3.33% of shares outstanding on 13 Aug 2021 to 4.70% on 31 Dec 2021, a change of +1.37 percentage points. The year's high was 5.77% on 30 Sep 2021 and its low 3.33% on 13 Aug 2021, averaging 4.87% across 10 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.42 days on 29 Oct 2021. Full history: LENZ Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 3.33% (13 Aug 2021)
- End of year
- 4.70% (31 Dec 2021)
- Change
- +1.37 pp
- High
- 5.77% (30 Sep 2021)
- Low
- 3.33% (13 Aug 2021)
- Average
- 4.87%
- Highest days to cover
- 22.42 (29 Oct 2021)
- SEC filings marked
- 4
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Aug 2021 | 3.33% | 5.28 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 3.86% | 8.32 | |
| 15 Sep 2021 | 4.68% | 10.35 | |
| 30 Sep 2021 | 5.77% | 5.88 | |
| 15 Oct 2021 | 5.42% | 11.52 | |
| 29 Oct 2021 | 5.38% | 22.42 | |
| 15 Nov 2021 | 5.08% | 21.79 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 5.04% | 12.95 | |
| 15 Dec 2021 | 5.42% | 11.83 | |
| 31 Dec 2021 | 4.70% | 8.04 |
See also: LENZ Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.